Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01318538 · ClinicalTrials.gov registry record · NA
Women's Recovery Group (WRG) Study - A Randomized Controlled Stage II Trial
A NA study, sponsored by Mclean Hospital.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT01318538 is a NA study that has completed, run by Mclean Hospital. The registered enrollment target is 158 participants.
The verdict
NCT01318538, a NA study, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
The purpose of this Stage II randomized controlled behavioral treatment development trial was to test the effectiveness of the Women's Recovery Group (WRG) relative to mixed-gender Group Drug Counseling (GDC) and demonstrate the feasibility of implementing the WRG in an open-enrollment (i.e., rolling admission) group format at two clinical sites. The Stage II trial aims were to (1) investigate effectiveness of the WRG relative to GDC in a sample of women heterogeneous with respect to substance use and co-occurring psychiatric disorders, and (2) demonstrate the feasibility of implementing WRG in an open enrollment group format characteristic of community treatment programs at two sites.
Interventions
- BEHAVIORAL The Women's Recovery Group
- BEHAVIORAL Group Drug Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01318538
The ClinicalTrials.gov registry entry for NCT01318538 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which The Women's Recovery Group is the first listed.
NCT01318538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01318538 about?
NCT01318538 is a clinical study titled "Women's Recovery Group (WRG) Study - A Randomized Controlled Stage II Trial". The purpose of this Stage II randomized controlled behavioral treatment development trial was to test the effectiveness of the Women's Recovery Group (WRG) relative to mixed-gender Group Drug Counseling (GDC) and demonstrate the feasibility of implementing the WRG in an open-enrollment (i.e., rollin...
What is the current status of trial NCT01318538?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2008-08. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01318538?
The interventions under investigation include: The Women's Recovery Group (BEHAVIORAL), Group Drug Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01318538?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.